US 7153880
Substituted diphenyl heterocycles useful for treating HCV infection
granted A61PA61P31/12A61P31/14
Quick answer
US patent 7153880 (Substituted diphenyl heterocycles useful for treating HCV infection) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61P, A61P31/12, A61P31/14, A61P43/00